SPOTLIGHT -
Slideshow
Author(s):
Sleep disturbance-including shorter sleep time and lowered sleep quality-is associated with increased psychotic experiences. So what's new?
FDA Committees Vote to Dismiss Clozapine REMS
Treating ‘Morally Objectionable’ Patients
Long-Acting Injectables and a Team-Driven Approach for Schizophrenia Treatment
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Emraclidine for Schizophrenia Fails to Meet Primary Endpoints in Phase 2 EMPOWER Trials
Schizophrenia Pharmacology: Version 2.0